Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials-Reference-Cited by-同舟云学术

Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials

Published:2018-05-09 Issue:8 Volume:14 Page:1077-1087
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Iwatsubo Takeshi¹²,Iwata Atsushi³,Suzuki Kazushi¹,Ihara Ryoko¹,Arai Hiroyuki⁴,Ishii Kenji⁵,Senda Michio⁶,Ito Kengo⁷,Ikeuchi Takeshi⁸,Kuwano Ryozo⁸,Matsuda Hiroshi⁹,Sun Chung‐Kai¹⁰,Beckett Laurel A.¹¹,Petersen Ronald C.¹²,Weiner Michael W.¹³,Aisen Paul S.¹⁰,Donohue Michael C.¹⁰, ,

Affiliation:

1. Unit for Early and Exploratory Clinical DevelopmentThe University of Tokyo HospitalTokyoJapan

2. Department of NeuropathologyGraduate School of MedicineThe University of TokyoTokyoJapan

3. Department of NeurologyThe University of Tokyo HospitalTokyoJapan

4. Department of GeriatricsTohoku UniversitySendaiJapan

5. Research Team for NeuroimagingTokyo Metropolitan Institute of GerontologyTokyoJapan

6. Division of Molecular ImagingInstitute of Biomedical Research and InnovationKobeJapan

7. Department of Clinical and Experimental NeuroimagingNational Center for Geriatrics and GerontologyObuJapan

8. Department of Molecular GeneticsBioresource Science BranchCenter for BioresourcesBrain Research InstituteNiigata UniversityNiigataJapan

9. Integrative Brain Imaging CenterNational Center for Neurology and PsychiatryKodairaJapan

10. Alzheimer's Therapeutics Research InstituteUniversity of Southern CaliforniaSan DiegoCAUSA

11. Division of BiostatisticsDepartment of Public Health SciencesUniversity of California, DavisDavisCAUSA

12. Department of NeurologyMayo ClinicRochesterMNUSA

13. Department of Veterans Affairs Medical CenterCenter for Imaging of Neurodegenerative DiseasesUniversity of CaliforniaSan FranciscoCAUSA

Funder

Japan Agency for Medical Research and Development

National Institutes of Health

ADNI

AMED

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.03.009

Reference26 articles.

1. Biomarker Modeling of Alzheimer’s Disease

2. Alzheimer disease in 2020;Holtzman D.M.;Cold Spring Harb Perspect Med,2012

3. A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

4. Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

5. Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contributions of the ADNI Biostatistics Core;Alzheimer's & Dementia;2024-08-14

2. 18F-FDG-PET-based deep learning for predicting cognitive decline in non-demented elderly across the Alzheimer’s disease clinical spectrum;Radiology Advances;2024-08-10

3. Efficacy of a non-pharmaceutical multimodal intervention program in a group setting for patients with mild cognitive impairment: A single-arm interventional study with pre-post and external control analyses;Contemporary Clinical Trials Communications;2024-08

4. How will the emergence of lecanemab change dementia treatment?;Geriatrics & Gerontology International;2024-07-21

5. A Longitudinal Study of CogEvo’s Prediction of Cognitive Decline in Older Adults;Healthcare;2024-07-10